CPT codes

53947 CPT codes with hospital pricing data in the network.

• CPT 555T — B1 STR&FX RSK TRANSMIS DATA (85 hospitals, — samples)
• CPT 555U — Reproductive medicine (preimplantation genetic assessment), analysis of 24 chromosomes using DNA genomic sequence analysis from embryonic trophectoderm for structural rearrangements, aneuploidy, ploidy, a mitochondrial DNA score, and embryo quality contro (33 hospitals, — samples)
• CPT 556T — B1 STR & FX RSK ASSESSMENT (85 hospitals, — samples)
• CPT 556U — Infectious disease (bacterial or viral respiratory tract infection), pathogen-specific DNA and RNA by real-time PCR, 12 targets, nasopharyngeal or oropharyngeal swab, including multiplex reverse transcription for RNA targets, each analyte reported as dete (33 hospitals, — samples)
• CPT 557T — B1 STR & FX RSK I&R (85 hospitals, — samples)
• CPT 557U — Infectious disease (bacterial vaginosis and vaginitis), real-time amplification of DNA markers for Atopobium vaginae, Gardnerella vaginalis, Megasphaera types 1 and 2, bacterial vaginosis associated bacteria-2 and -3 (BVAB-2, BVAB-3), Mobiluncus species, (33 hospitals, — samples)
• CPT 55881 — ABLT TRURL PRST8 TIS THRM US (494 hospitals, — samples)
• CPT 558T — CT SCAN F/BIOMCHN CT ALYS (85 hospitals, — samples)
• CPT 558U — Oncology (colorectal), quantitative enzyme-linked immunosorbent assay (ELISA) for secreted colorectal cancer protein marker (BF7 antigen), using serum, result reported as indicative of response/no response to therapy or disease progression/regression (33 hospitals, — samples)
• CPT 559T — ANTMC MDL 3D PRINT 1ST CMPNT (85 hospitals, — samples)
• CPT 559U — Oncology (breast), quantitative enzyme-linked immunosorbent assay (ELISA) for secreted breast cancer protein marker (BF9 antigen), serum, result reported as indicative of response/no response to therapy or disease progression/regression (33 hospitals, — samples)
• CPT 55U — CARD HRT TRNSPL 96 DNA SEQ (85 hospitals, — samples)
• CPT 560 — Anes px heart w/o pump oxtj (91 hospitals, — samples)
• CPT 560T — ANTMC MDL 3D PRINT EA ADDL (85 hospitals, — samples)
• CPT 560U — Oncology (minimal residual disease [MRD]), genomic sequence analysis, cell-free DNA, whole blood and tumor tissue, baseline assessment for design and construction of a personalized variant panel to evaluate current MRD and for comparison to subsequent MRD (33 hospitals, — samples)
• CPT 561 — ANESTH HEART SURG <1 YR (91 hospitals, — samples)
• CPT 561T — ANTMC GUIDE 3D PRINT 1ST GD (85 hospitals, — samples)
• CPT 561U — Oncology (minimal residual disease [MRD]), genomic sequence analysis, cell-free DNA, whole blood, subsequent assessment with comparison to initial assessment to evaluate for MRD (33 hospitals, — samples)
• CPT 562 — ANESTH HRT SURG W/PMP AGE 1+ (91 hospitals, — samples)
• CPT 562T — ANTMC GUIDE 3D PRINT EA ADDL (85 hospitals, — samples)
• CPT 562U — Oncology (solid tumor), targeted genomic sequence analysis, 33 genes, detection of single-nucleotide variants (SNVs), insertions and deletions, copy-number amplifications, and translocations in human genomic circulating cell-free DNA, plasma, reported as (33 hospitals, — samples)
• CPT 563T — EVAC MEIBOMIAN GLND HEAT BI (85 hospitals, — samples)
• CPT 563U — Infectious disease (bacterial and/or viral respiratory tract infection), pathogen-specific nucleic acid (DNA or RNA), 11 viral targets and 4 bacterial targets, qualitative RT-PCR, upper respiratory specimen, each pathogen reported as positive or negative (33 hospitals, — samples)
• CPT 564T — ONC CHEMO RX CYTOTOX CSC 14 (61 hospitals, — samples)
• CPT 564U — Infectious disease (bacterial and/or viral respiratory tract infection), pathogen-specific nucleic acid (DNA or RNA), 10 viral targets and 4 bacterial targets, qualitative RT-PCR, upper respiratory specimen, each pathogen reported as positive or negative (33 hospitals, — samples)
• CPT 565T — AUTOL CELL IMPLT ADPS HRVG (85 hospitals, — samples)
• CPT 565U — Oncology (hepatocellular carcinoma), next-generation sequencing methylation pattern assay to detect 6626 epigenetic alterations, cell-free DNA, plasma, algorithm reported as cancer signal detected or not detected (33 hospitals, — samples)
• CPT 566T — AUTOL CELL IMPLT ADPS NJX (85 hospitals, — samples)
• CPT 566U — Oncology (lung), qPCR-based analysis of 13 differentially methylated regions (CCDC181, HOXA7, LRRC8A, MARCHF11, MIR129-2, NCOR2, PANTR1, PRKCB, SLC9A3, TBR1_2, TRAP1, VWC2, ZNF781), pleural fluid, algorithm reported as a qualitative result (33 hospitals, — samples)
• CPT 567 — ANESTH CABG W/PUMP (91 hospitals, — samples)
• CPT 567T — PERM FLP TUBE OCCLS W/IMPLT (67 hospitals, — samples)
• CPT 567U — Rare diseases (constitutional/heritable disorders), whole-genome sequence analysis combination of short and long reads, for single-nucleotide variants, insertions/deletions and characterized intronic variants, copy-number variants, duplications/deletions, (33 hospitals, — samples)
• CPT 568T — INTRO MIX SALINE&AIR F/SSG (64 hospitals, — samples)
• CPT 568U — Neurology (dementia), beta amyloid (Aβ40, Aβ42, Aβ42/40 ratio), tau-protein phosphorylated at residue (eg, pTau217), neurofilament light chain (NfL), and glial fibrillary acidic protein (GFAP), by ultra-high sensitivity molecule array detection, plasma, a (33 hospitals, — samples)
• CPT 569T — TTVR PERQ APPR 1ST PROSTH (78 hospitals, — samples)
• CPT 569U — Oncology (solid tumor), next-generation sequencing analysis of tumor methylation markers (>20000 differentially methylated regions) present in cell-free circulating tumor DNA (ctDNA), whole blood, algorithm reported as presence or absence of ctDNA with tu (33 hospitals, — samples)
• CPT 56U — Whole Genome Sequencing In Blood Or Bone Marrow For Acute Myelogenous Leukemia (7 hospitals, — samples)
• CPT 570T — TTVR PERQ EA ADDL PROSTH (78 hospitals, — samples)
• CPT 570U — Neurology (traumatic brain injury), analysis of glial fibrillary acidic protein (GFAP) and ubiquitin carboxyl-terminal hydrolase L1 (UCH-L1), immunoassay, whole blood or plasma, individual components reported with the overall result of elevated or non-ele (33 hospitals, — samples)
• CPT 571T — INSJ/RPLCMT ICDS SS ELTRD (78 hospitals, — samples)
• CPT 571U — Oncology (solid tumor), DNA (80 genes) and RNA (10 genes), by next-generation sequencing, plasma, including single-nucleotide variants, insertions/deletions, copy-number alterations, microsatellite instability, and fusions, reported as clinically actionab (33 hospitals, — samples)
• CPT 572T — INSERTION SS DFB ELECTRODE (79 hospitals, — samples)
• CPT 572U — Oncology (prostate), high-throughput telomere length quantification by FISH, whole blood, diagnostic algorithm reported as risk of prostate cancer (33 hospitals, — samples)
• CPT 573T — REMOVAL SS DFB ELECTRODE (79 hospitals, — samples)
• CPT 573U — Oncology (pancreas), 3 biomarkers (glucose, carcinoembryonic antigen, and gastricsin), pancreatic cyst lesion fluid, algorithm reported as categorical mucinous or non-mucinous (33 hospitals, — samples)
• CPT 574T — REPOS PREV SS IMPL DFB ELTRD (79 hospitals, — samples)
• CPT 574U — Mycobacterium tuberculosis, culture filtrate protein-10-kDa (CFP-10), serum or plasma, liquid chromatography mass spectrometry (LC-MS) (33 hospitals, — samples)
• CPT 575T — PRGRMG DEV EVAL ICDS SS IP (80 hospitals, — samples)
• CPT 576T — INTERROG DEV EVAL ICDS SS IP (80 hospitals, — samples)
• CPT 577T — EPHYS EVAL ICDS SS (85 hospitals, — samples)